Bioorganic and Medicinal Chemistry Letters p. 907 - 911 (2010)
Update date:2022-09-26
Topics:
Lowe III, John A.
DeNinno, Shari L.
Drozda, Susan E.
Schmidt, Christopher J.
Ward, Karen M.
David Tingley III
Sanner, Mark
Tunucci, Don
Valentine, James
We describe a novel series of inhibitors of the type 1 glycine transporter (GlyT1) as an approach to relieving the glutamatergic deficit that is thought to underlie schizophrenia. Synthesis and SAR follow-up of a series of octahydro-cyclopenta[c]pyrrole derivatives afforded potent in vitro inhibition of GlyT1 as well as in vivo activity in elevating CSF glycine. We also found that a 3-O(c-pentyl), 4-F substituent may serve as a surrogate for the widely used 3-trifluoromethoxy group, suggesting its application as an isostere for future medicinal chemistry studies.
View Morewebsite:http://www.oceanchem-group.com
Contact:86-536-8596048
Address:9th floor,Building B future Plaza, No.88.Fenghuang Street,Weifang,Shandong,China
Contact:+86-10-67147360/67107388
Address:No.18 Guangming Zhongjie, Chongwen District, Beijing, 100061, China
Shuanghe Bio-Technology Limited(expird)
Contact:+86-571-61710758,18968016640
Address:Jinqiao north road 916# Fuyang
Zhengzhou Minzhong Pharmaceutical Co.,ltd
Contact:0086-371-65797115
Address:15/F,Jiangshan Bldg, NO.126 Huanghe Road,Zhengzhou, China
Hebei Fulong Import & Export Co., Ltd.
Contact:86-311-87795661
Address:15A19 Zhongyuan Building,368 Youyi North Street,Shijiazhuang 050070,China
Doi:10.1016/S0040-4020(01)86080-4
(1988)Doi:10.1016/S0277-5387(00)86440-2
(1989)Doi:10.3762/bjoc.15.48
(2019)Doi:10.1002/jhet.292
(2010)Doi:10.1021/ja201561z
(2011)Doi:10.1016/j.tet.2017.12.015
(2018)